title: Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma.
authors.affiliation: Division of Urology, University of Colorado Health Sciences Center, Denver 80262.
authors.forename: J E
authors.initials: JE
authors.lastname: Foote
authors.forename: E D
authors.initials: ED
authors.lastname: Crawford
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000628:therapy*; D000726:Androgen Antagonists / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D007016:Hypophysectomy; D008297:Male; D009367:Neoplasm Staging; D009919:Orchiectomy; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D011897:Random Allocation
chemical_list: D000726:Androgen Antagonists